| Number of subjects |
211 |
66 |
145 |
— |
| Age, y |
3.6 ± 1.3 |
3.6 ± 1.5 |
3.6 ± 1.2 |
0.25 |
| Male % |
51.5 |
51.3 |
51.7 |
0.86 |
| NT-proBNP, ng/L |
1396 |
3640 |
656 |
<0.001 |
| Body temperature, °C |
39 ± 0.7 |
39 ± 0.8 |
39 ± 0.5 |
0.58 |
| Heart rate, beats/min |
120 ± 15 |
145 ± 20 |
95 ± 10 |
<0.05 |
| Breath rate, breathes/min |
45 ± 5 |
55 ± 6 |
35 ± 4 |
<0.05 |
| Liver enlargement, cm |
2 ± 1.0 |
4 ± 0.5 |
1 ± 0.5 |
<0.001 |
| Plasma glucose, mmol/L |
8.7 ± 1.8 |
9.6 ± 1.7 |
7.8 ± 1.8 |
0.17 |
| White blood cell increase, ×109/ L |
15 ± 2.7 |
16 ± 3.1 |
14 ± 2.3 |
0.47 |
| White blood cell decrease, ×109/ L |
3.0 ± 0.8 |
3.0 ± 0.7 |
3.0 ± 0.9 |
0.28 |
| Platelet, 10 × 109/ L |
7.4 ± 0.3 |
5.3 ± 0.2 |
9.4 ± 0.4 |
<0.05 |
| Hemoglobin, g/L |
69 ± 14 |
62 ± 12 |
87 ± 17 |
0.07 |
| Serum total bilirubin, mmol/L |
77 ± 23.3 |
98 ± 33.8 |
55 ± 12.7 |
<0.05 |
| Alanine transaminase, U/L |
59 ± 17 |
82 ± 15 |
36 ± 18 |
<0.001 |
| C reaction protein, mg/L |
39 ± 6.4 |
48 ± 11.2 |
29 ± 0.6 |
<0.05 |
| Procalcitonin, mg/L |
14 ± 1.1 |
16 ± 2.6 |
11 ± 0.5 |
<0.001 |
| Blood lactic acid, mmol/L |
5 ± 0.9 |
6 ± 1.2 |
4 ± 0.6 |
<0.05 |
| Activated partial thromboplastin time, s |
70 ± 14.8 |
95 ± 12.5 |
45 ± 17.1 |
<0.001 |
| TNF-α, pg/mL |
42 ± 15.2 |
52 ± 15.3 |
31 ± 16.1 |
<0.05 |
| IL6, pg/mL |
61 ± 11.3 |
77 ± 11.9 |
44 ± 10.6 |
<0.05 |
| Ejection fraction, % |
45 ± 9.5 |
25 ± 10.4 |
65 ± 8.5 |
<0.001 |
| E peak /A peak |
1.5± 0.2 |
1.4± 0.2 |
1.6± 0.2 |
0.12 |
| Arterial oxygen saturation, % |
44 ± 14.9 |
33 ± 16.4 |
55 ± 13.4 |
<0.05 |
| Systolic blood pressure, mmHg |
89 ± 11.5 |
85 ± 11.6 |
92 ± 12.5 |
0.42 |
| Urine volume, mg·kg-1·min-1
|
0.3 ± 0.05 |
0.2 ± 0.05 |
0.4 ± 0.05 |
<0.05 |
| Capillary filling, s |
4 ± 1.0 |
5 ± 1.0 |
3 ± 1.0 |
<0.05 |
